Cerebrocrast, a cognition enhancer and neuroprotectant: Focus on mitochondrial functions

Autonomic and Autacoid Pharmacology

Volumn 26, Issue 1, 2006, Pages 60-62

  Klusa, V ^a  

^a UNIVERSITY OF LATVIA   (Latvia)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; BICUCULLINE; CEREBROCRAST; DIAZEPAM; PENTETRAZOLE; THIOSEMICARBAZIDE;

ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BRAIN MITOCHONDRION; CELL DEATH; CELL FUNCTION; CENTRAL NERVOUS SYSTEM FUNCTION; COGNITION; CONCENTRATION RESPONSE; CONFERENCE PAPER; COORDINATION; CYTOKINE RELEASE; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG TARGETING; GABAERGIC TRANSMISSION; HUMAN; IN VIVO STUDY; LEARNING; LOCOMOTION; MEMORY CONSOLIDATION; NERVE DEGENERATION; NERVOUS TISSUE; NEUROPROTECTION; NONHUMAN; PAW EDEMA;

EID: 33644955587     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. FERNANDES, M.A.S., SANTOS, M.S., VICENTE, J.A.F., MORENO, A.J.M., VELENA, A., DUBURS, G. & OLIVEIRA, C.R. (2003). Effects of 1,4-dihydropyridine derivatives (cerebrocrast, gammapyrone, glutapyrone, and diethone) on mitochondrial bioenergetics and oxidative stress: a comparative study. Mitochondrion, 3, 47-59.
2. JANSONE, B., MUCENIECE, R., KLUSA, V., SVIRSKIS, S., DUBURS, G. & WIKBERG, J.E.S. (2004). The non-peptide ligand cerebrocrast is a highly selective melanocortin MC4 receptor agonist and inhibits feeding. Proceedings Latvian Academy of Sciences, Part B, 58, 3/4, 103-108.
3. KARPOVA, M.M., PANKOV, O.YU., GLEBOV, R.N., DUBUR, G.YA., GERMANE, S.K. & KLUSA, V.E. (1991). [Antiepileptic effects of IOS-1.1212, a novel blockator of Ca-channels]. Biull. Eksp.Biol. Med., 1991, N 10, 362-365 (in Russ.).
4. KLEGERIS, A., LIUTKEVICIUS, E., MIKALAUSKIENE, G., DUBURS, G., MCGEER, P.L. & KLUSA, V. (2002) Anti-inflammatory effects of cerebrocrast in a model of rat paw edema and on human mononuclear phagocytes Eur. J. Pharmacol., 441, 203-208.
5. KLUSA, V. (1995). Cerebrocrast (IOS-1.1212). Neuroprotectant, Cognition Enhancer. Drugs of the Future., 20, 135-138.
6. KLUŠA, V., DUBURS, G., GĒRMANE, S., MUCENIECE, R., CĒBERS, G., MISĀNE, I., BISENIEKS, E., LIEPA, I. & DAMBROVA, M. (1992). Structure and activity peculiarities of Cerebrocrast (IOS-1.1212), a novel type of CNSmodulating 1,4-dihydropyridines. Proceedings Latvian Academy of Sciences, Part B, N 9, 51-55.
7. KLUSA, V., SEMENOVA, T.D., MEDVINSKAYA, N.I. & FAST, A.E. (1995) Cerebrocrast (IOS-1212) normalizes disturbances of learning, attention, emotional behaviour and brain biogenic amine levels in prenatally hypoxized rats. Proceedings Latvian Academy of Sciences, Part B, N11/12, 156-161.
8. MISANE, I. (1993). Brain function enhancing activity of cerebrocrast, a novel type of the 1,4-dihydropyridine compounds. PhD Thesis, Riga, Institute of Molecular Biology, 79p.
9. MUCENIECE R, LIEPA I., DAMBROVA M., BLEIDELIS E., SVIRSKIS S. & KLUSA V. (1991). Stress-protective action of 1,4-dihydropyridines. In: Pharmacology of Novel Centrally and Peripherally Acting Drugs, pp. 51-52. Institute of Organic Synthesis, Riga.
10. VELENA, A., SKUJINS, A., SVIRSKIS, S., BISENIEKS, E., ULDIKIS, J., POIKANS, J., DUBURS, G. & KLUSA, V. (1997). Modification of swelling-contraction-aggregation processes in rat muscle mitochondria by the 1,4-dihydropyridines, Cerebrocrast and Glutapyrone, themselves and in presence of azidothymidine. Cell Biochem. Function., 15, 211-220.
11. YOUDIM, M.B.H.&BUCCAFUSCO, J.J. (2005). Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders. Trends Pharmacol. Sci., 26, 27-35.